Digital Holter Monitor has recording time of up to 7 days.
Share:
Press Release Summary:
Weighing 1.75 oz and equipped with LCD, DL900 helps increase diagnostic yield and provides extended recording time. It incorporates custom analog IC for signal acquisition and combines USB transfer capability with support for use of removable SD memory card. Along with recording resolutions and sampling rates suitable for clinical and research applications, monitor offers programmable pacemaker detection capability and capacity to support multiple OEM capabilities.
Original Press Release:
Braemar Introduces the DL900 Advanced Holter Monitor
DL900 Showcased at ACC and HRS conferences
MINNEAPOLIS, May 30 -- Braemar, Inc., a subsidiary of Biotel, Inc. (BULLETIN BOARD: BTEL) and a world leader in ambulatory cardiac monitoring devices, has introduced the DL900, an advanced digital Holter monitor. At 1.75 ounces, the new monitor is more compact and discrete than earlier models, yet provides a large liquid crystal display (LCD) and extended recording time of up to seven days. A newly designed, custom analog IC for signal acquisition is the technology platform for the advanced capabilities of the DL900. The device was showcased at the recent American College of Cardiologists (ACC) conference in Chicago and the Heart Rhythm Society (HRS) conference in San Francisco.
"The DL900 was enthusiastically received at both ACC and HRS," Harry Strandquist, President and CEO of Braemar, Inc. commented. "Our partners are in the process of integrating this new device into their ambulatory cardiac monitoring product lines."
The DL900 increases diagnostic yield and provides extended recording time of several days or more for clinical research applications. The device combines high speed USB transfer capability with the ability to use a removable SD memory card. The DL900 provides high-resolution recordings as well as high sampling rate options suitable for both clinical and research applications. A programmable pacemaker detection capability provides the clinician with additional data.
The DL900's advanced technology platform has the capacity to support numerous OEM capabilities, including multi parameter recording and data storage of a variety of physiological signals.
For photo, go to http://www.biotelinc.com/images/BraemarDL900.jpg.
Braemar, Inc., designs, develops, engineers and manufactures ambulatory cardiac monitoring and other medical devices. The company provides high- quality, reliable devices to OEM partners worldwide.
CONTACT: Harry Strandquist of Biotel, Inc., +1-651-286-8620, info@biotelinc.com
